S

STALICLA

23 employees

STALICLA is a Swiss biotechnology company developing precision medicine treatments for patients with Neurodevelopmental disorders

Basic info

Industry

biotechnology research

Sectors

Autism
NDDs
Biotechnology
ASD
Innovation
Neuroscience
Big data
Neurodevelopmental Disorders
Research
Personalized medicine
Financing research

Date founded

2017

Funding rounds raised

Total raised

$11M

from 2 investors over 2 rounds

S

STALICLA raised $564K on December 20, 2021

Investors: LIFTT

S

STALICLA raised $11M on July 31, 2020

Investors: AA & SONS

FAQ